Physician profile
Divya Bhandari
NPI 1922109792
$1,622.99
in general payments reported to CMS, 2019-2025
11 companies · $336 in 2025
The $336 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $21.10 · 2021: $43.83 · 2022: $19.59 · 2023: $185 · 2024: $1,017 · 2025: $336.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,538.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,538.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lumenis Be INC | $550.31 | 2024 | Optilight |
| Lkc Technologies, INC. | $223.13 | 2024 | |
| Tarsus Pharmaceuticals, INC. | $181.07 | 2025 | Xdemvy |
| Bausch & Lomb Americas INC. | $124.99 | 2024 | Xiidra, Miebo |
| Johnson & Johnson Vision Care, INC. | $122.79 | 2021-2025 | Acuvue |
| Oyster Point Pharma, INC. | $115.29 | 2023 | Tyrvaya |
| Biotissue Holdings INC. | $107.97 | 2025 | |
| Alcon Vision LLC | $83.74 | 2020-2025 | Dailies Total1, Total30, Precision 1 |
| Rxsight INC | $63.02 | 2024 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Injector Cartridge |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $26.19 | 2021 | |
| Abbott Laboratories | $24.49 | 2024 | Epic |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Divya Bhandari listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.